Literature DB >> 24858190

Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.

Abu Bakar Hafeez Bhatti1, Mohammad Aasim Yusuf, Syed Ather Saeed Kazmi, Aamir Ali Syed.   

Abstract

BACKGROUND: The technical complexity of pancreatic resection has made it a specialized procedure performed in high-volume centers. It has been shown that patients operated on in high-volume pancreatobiliary centers have fewer complications and better survival. The purpose of this study was to share our experience with and report long-term outcomes of pancreaticoduodenal resections performed in a low-volume center in Pakistan.
METHODS: Data of patients who underwent pancreaticoduodenal resection for adenocarcinoma at our institute from 1999 to 2012 were reviewed. A total of 39 patients were included in the study. Variables included patients' clinical and histopathological characteristics. Outcome was determined based on complication rate, 30- and 90-day mortality, disease-free survival, and overall survival. For survival analysis, Kaplan-Meier curves were used and significance was determined using a log rank test. Univariate Cox analysis was performed to determine significant factors for multivariate analysis.
RESULTS: The majority of tumors [20 (51 %)] were moderate grade, T1/T2 [20 (51 %)], ampullary adenocarcinomas [18 (46 %)]. Mean hospital stay was 14 ± 8 days. The mean number of nodes removed was 13.9 ± 6.9, while mean number of positive nodes was 1 ± 1.7. Expected 5-year overall survival and relapse-free survival were 38 and 48 %, respectively. Overall 5-year survival was significantly different with respect to nodal involvement, i.e., 47 vs. 28 % (P = 0.018). On univariate analysis, nodal involvement was the only factor associated with an increased risk of death (P = 0.02, hazard ratio [HR] 2.9, confidence interval [CI] 1.1-7.8).
CONCLUSION: Low-volume centers are an acceptable alternate to high-volume centers for performing pancreaticoduodenal resection in carefully selected patients. Efforts should be directed at developing specialized hepatobiliary centers in developing countries.

Entities:  

Mesh:

Year:  2014        PMID: 24858190     DOI: 10.1007/s00268-014-2644-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

Review 1.  Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.

Authors:  N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 2.  Resection margins and R1 rates in pancreatic cancer--are we there yet?

Authors:  C S Verbeke
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

3.  Surgical outcomes and prognostic factors for ampulla of Vater cancer.

Authors:  S B Choi; W B Kim; T J Song; S O Suh; Y C Kim; S Y Choi
Journal:  Scand J Surg       Date:  2011       Impact factor: 2.360

4.  Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis.

Authors:  Chang-Peng Zhu; Jian Shi; Yue-Xiang Chen; Wei-Fen Xie; Yong Lin
Journal:  Radiother Oncol       Date:  2011-05-14       Impact factor: 6.280

5.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

6.  Pancreaticoduodenectomy: a developing country perspective.

Authors:  Khawaja Muhammad Inam Pal; Hassaan Bari; Sana Nasim
Journal:  J Pak Med Assoc       Date:  2011-03       Impact factor: 0.781

7.  Outcome analysis of pancreaticoduodenectomy at a community hospital.

Authors:  Alan Afsari; Zhou Zhandoug; Shun Young; Lorenzo Ferguson; Sumet Silapaswan; Vijay Mittal
Journal:  Am Surg       Date:  2002-03       Impact factor: 0.688

8.  Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Authors:  Axel Richter; Marco Niedergethmann; Jörg W Sturm; Dietmar Lorenz; Stefan Post; Michael Trede
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

9.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

10.  Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.

Authors:  Rita A Mukhtar; Omar M Kattan; Hobart W Harris
Journal:  HPB Surg       Date:  2009-02-25
View more
  1 in total

1.  Complications among Patients Undergoing Pancreaticoduodenectomy in Tertiary Care Centers of Nepal: A Descriptive Cross-sectional Study.

Authors:  Harish Chandra Neupane; Tseten Yonjen Tamang; Santosh Timalsina; Kishor Kumar Tamrakar; Abhishek Bhattarai
Journal:  JNMA J Nepal Med Assoc       Date:  2022-01-15       Impact factor: 0.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.